Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -85.72% is in line with its 5-year average of -83.89%, around the middle of its 5-year range (-174.21%–-14.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.58% below its 12-month average of -76.14%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -85.72%.
RETURN ON INVESTED CAPITAL (ROIC)
-85.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-76.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-115.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-83.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-12.58%
CURRENT VS 3Y AVG
+25.49%
CURRENT VS 5Y AVG
-2.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 766 covered companies
CURRENT VS SECTOR MEDIAN
-148.93%
vs the sector median at left
Bionano Genomics, Inc.
Market Cap
$16.52M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-76.14%
3Y Avg
-115.05%
5Y Avg
-83.89%
Market Cap
$16.50M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$17.01M
Return on Invested Capital (ROIC)
-88.07%
TTM Avg
-68.32%
3Y Avg
-78.67%
5Y Avg
-76.64%
Market Cap
$17.14M
Return on Invested Capital (ROIC)
-125.44%
TTM Avg
-125.44%
3Y Avg
-1118.57%
5Y Avg
-719.84%
Market Cap
$17.15M
Return on Invested Capital (ROIC)
-57.74%
TTM Avg
-38.37%
3Y Avg
-49.64%
5Y Avg
-45.59%
Market Cap
$16.08M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-183.21%
3Y Avg
-122.71%
5Y Avg
-100.21%
Market Cap
$17.23M
Return on Invested Capital (ROIC)
-73.92%
TTM Avg
-122.57%
3Y Avg
-184.65%
5Y Avg
-161.38%
Market Cap
$15.78M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
Market Cap
$17.60M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.52M | -85.72% | -76.14% | -115.05% | -83.89% |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | -279.48% | -96.52% | -105.30% | -89.17% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | -88.07% | -68.32% | -78.67% | -76.64% |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | -125.44% | -125.44% | -1118.57% | -719.84% |
| Lipocine Inc. (LPCN)vs › | $17.15M | -57.74% | -38.37% | -49.64% | -45.59% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $16.08M | N/A | -183.21% | -122.71% | -100.21% |
| PAVmed Inc. (PAVM)vs › | $17.23M | -73.92% | -122.57% | -184.65% | -161.38% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | -273.70% | -707.06% | -535.27% | -358.40% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.60M | N/A | -171.06% | -106.73% | -106.73% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.59M | -41.81% | -159.62% | -298.97% | -203.41% |
ROIC
-85.7%
ROE
-101.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -85.72% |
| 2026-03-31 | -60.00% |
| 2025-12-31 | -65.83% |
| 2025-09-30 | -55.75% |
| 2025-06-30 | -113.39% |
| 2025-03-31 | -125.03% |
| 2024-12-31 | -174.21% |
| 2024-09-30 | -161.57% |
| 2024-06-30 | -162.61% |
| 2024-03-31 | -157.25% |
| 2023-12-31 | -113.42% |
| 2023-09-30 | -159.76% |
| 2023-06-30 | -61.09% |
| 2023-03-31 | -54.96% |
| 2022-12-31 | -48.49% |
| 2022-09-30 | -42.37% |
| 2022-06-30 | -37.97% |
| 2022-03-31 | -29.09% |
| 2021-12-31 | -21.60% |
| 2021-09-30 | -17.38% |
| 2021-06-30 | -14.16% |
| 2021-03-31 | -10.58% |
| 2020-12-31 | -74.85% |
| 2020-09-30 | -112.09% |
| 2020-06-30 | -138.87% |
| 2020-03-31 | -228.61% |
| 2019-12-31 | -108.15% |
| 2019-09-30 | -195.02% |
| 2019-06-30 | -135.88% |
| 2019-03-31 | -89.64% |
| 2018-12-31 | -100.67% |
| 2018-09-30 | -77.74% |
| 2018-06-30 | -186.24% |
| 2018-03-31 | -222.13% |
